Ardelyx reported $-37.6M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Amgen USD 2.38B 556M Jun/2026
Ardelyx USD -37.6M 37.2M Mar/2026
aTyr Pharma USD -153K 24.71M Mar/2026
Corcept Therapeutics USD 42.14M 73.9M Jun/2026
Curis USD -24.2M 43.56M Mar/2026
Sanofi EUR 1.61B 2.42B Mar/2026
TG Therapeutics USD 7.78M 12M Jun/2026
United Therapeutics USD 333M 58.1M Jun/2026